NRBO - NeuroBo Pharmaceuticals Total Company Value
This price visualization of the individual enterprise value for NeuroBo Pharmaceuticals (NRBO) on GURU.Markets recorded a figure of . The financial success of NeuroBo Pharmaceuticals (NRBO) is based on the market launch of treatments for obesity and steatohepatitis. The company's development is constrained by the framework of FDA-supervised clinical trials, while a steady inflow of capital is secured by a staff of top neurobiologists attracted by competitive employment terms.
NeuroBo Pharmaceuticals - analytical breakdowns and key metrics (NRBO)
- stock quotes and analyst forecast:
- market capitalization statistics:
- business book valuation details:
- debt level and financial liquidity data:
Debt to Capital NeuroBo Pharmaceuticals|NRBO - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital neurobopharma.com|NRBO - Company Debts|Debt to Net Assets Ratio NeuroBo Pharmaceuticals|NRBO - Company Long-Term Debt|Short-Term Debt NeuroBo Pharmaceuticals|Immediate Liquidity Ratio neurobopharma.com
- earnings and market multiples details:
Analysis of all company metrics:NeuroBo Pharmaceuticals Inc
Enterprise value represents the total acquisition cost of a business, combining market capitalization with net debt minus liquid assets. By analyzing the market value of the business adjusted for net debt, an investor sees the actual costs of acquiring NeuroBo Pharmaceuticals (NRBO), which are currently influenced by geopolitical risks and biomaterial supply chain disruptions that are slowing the release of neurological drugs.
Competitors of NeuroBo Pharmaceuticals (NRBO)
Value Adjusted for Debt and Cash BIIB|Neurocrine Biosciences Inc - Enterprise Value|RGC: Total Company Value|Axsome Therapeutics (AXSM) - Total Company Value|Total Enterprise Value acadia-pharm.com (ACAD)|Total Company Value Xenon|Business Value VKTX (Viking Therapeutics Inc)|Enterprise Value SUPN|CPRX - Total Enterprise Value|Denali Therapeutics - Real Price to Acquire Entire Company|Enterprise Value harmonybiosciences.com HRMY|BHVN - Total Company Value|Value Adjusted for Debt and Cash AMLX (Amylyx Pharmaceuticals Inc)|Trevi Pharma (TRVI) - Total Company Value|Total Enterprise Value Praxis Corp (PRAX)|Total Company Value Anavex Life Sciences|Business Value CBLL (ceribell.com)|Enterprise Value PRTA|ALEC - Total Enterprise Value|Annexon Inc. - Real Price to Acquire Entire Company|Enterprise Value Omeros Corp OMER|NGNE - Total Company Value|Value Adjusted for Debt and Cash ACIU (acimmune.com)|Voyager Therapeutics, Inc. (VYGR) - Total Company Value|Total Enterprise Value Neumora (NMRA)|SCLX (Scilex Holding Co.) - Enterprise Value|Total Company Value TVGN|Total Company Value Alpha Cognition (ACOG)|CGTX - Total Enterprise Value|Inhibikase Therapeutics, Inc. - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash SAVA|ASRT - Total Company Value|Full Business Value COYA|VTGN: Enterprise Value|Ovid Therapeutics - Value Adjusted for Debt and Cash|ABOS (Acumen Pharmaceuticals, Inc.) - Enterprise Value|Enterprise Value CervoMed, Inc.|Total Company Value Alterity Therapeutics (ATHE)|CLNN (clene.com) - Value Adjusted for Debt and Cash|Total Company Value PepGen PEPG|JUNS - Real Price to Acquire Entire Company|Relmada Therapeutics, Inc. - Enterprise Value|ANVS - Enterprise Value|GRCE: Enterprise Value|Real Price to Acquire Entire Company Firefly Neuro|KLTO (ANEW Medical) - Enterprise Value|Total Enterprise Value NeuroSense Therapeutics, Ltd. NRSN|Real Price to Acquire Entire Company RVPH (Reviva Pharmaceuticals Holdings, Inc.)|Enterprise Value metaviatx.com (MTVA)|NeurAxis, Inc - Real Price to Acquire Entire Company|Aggregate Business Value HSDT (Helius Medical Technologies, Inc.)|Passage Bio Corp - Enterprise Value|Company Buyout Price Neuphoria Therapeutics Inc. NEUP|NERV: Enterprise Value|Real Price to Acquire Entire Company Athira Pharma Inc|ADXN (Addex Therapeutics, Ltd.) - Enterprise Value|Enterprise Value Alzamend|Total Company Value Cyclerion Therapeutics (CYCN)|Total Company Value PTIX (protagenic.com)|Total Company Value Pasithea Therapeutics Corp. KTTA|Company Buyout Price Cortigent Inc (CRGT)|ATXI - Total Company Value|BCLI (BrainStorm Cell Therapeutics Inc.) - Business Value|Cara Therapeutics, Inc. (CARA) - Total Company Value|chromocell.com - Value Adjusted for Debt and Cash|ELYM (Eliem Therapeutics, Inc.) - Enterprise Value|Total Company Value ITCI|Total Company Value Longboard Pharma (LBPH)|MRNS - Total Enterprise Value|Total Company Value NKGen Biotech, Inc. NKGN|SAGE: Business Value|Synaptogenix - Enterprise Value|Total Enterprise Value Trevena Inc.|VIGL (vigilneuro.com) - Real Price to Acquire Entire Company|anewmeds.com (WENA) - Enterprise Value|Total Company Value Cerevel Therapeutics